Evidence map›Paper›PMID 22720009›Full record

ArticlePloS one2012

Superinfection by discordant subtypes of HIV-1 does not enhance the neutralizing antibody response against autologous virus.

Luzia M Mayr, Rebecca L Powell, Johnson N Ngai, William A Takang, Arthur Nádas, Phillipe N Nyambi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Luzia M MayrDepartment of Pathology, New York University School of Medicine, New York, New York, United States of America.
Rebecca L Powell
Johnson N Ngai
William A Takang
Arthur Nádas
Phillipe N Nyambi
New York University · USUniversity Teaching Hospital of Yaounde · CM

Funding

TRAINING PROGRAM IN TB AND HIV PREVENTION AND TREATMENTD43TW001409 · FIC · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LAAL, SUMAN · 2000 to 2011
$4.6M
Viral Evolution and Humoral Immune Response to Dual HIV-1 InfectionR01AI083142 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GORNY, MIROSLAW K · 2010 to 2015
$2.6M
Improving Research Capacity in Cameroon for Studies on HIV-Associated MalignanciesD43CA153726 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NYAMBI, PHILLIPE N · 2010 to 2014
$2.0M
Viral Evolution and Humoral Immune Response to Dual HIV-1 InfectionR56AI083142 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NYAMBI, PHILLIPE N · 2009 to 2009
$407k
FIC NIH HHS D43 TW001409FIC NIH HHS TW01409NCI NIH HHS CA153726NCI NIH HHS D43 CA153726NIAID NIH HHS AI083142NIAID NIH HHS R01 AI083142NIAID NIH HHS R56 AI083142
6 · The paper itself

Abstract

Recent studies have demonstrated that both the potency and breadth of the humoral anti-HIV-1 immune response in generating neutralizing antibodies (nAbs) against heterologous viruses are significantly enhanced after superinfection by discordant HIV-1 subtypes, suggesting that repeated exposure of the immune system to highly diverse HIV-1 antigens can significantly improve anti-HIV-1 immunity. Thus, we investigated whether sequential plasma from these subjects superinfected with discordant HIV-1 subtypes, who exhibit broad nAbs against heterologous viruses, also neutralize their discordant early autologous viruses with increasing potency. Comparing the neutralization capacities of sequential plasma obtained before and after superinfection of 4 subjects to those of matched plasma obtained from 4 singly infected control subjects, no difference in the increase in neutralization capacity was observed between the two groups (p = 0.328). Overall, a higher increase in neutralization over time was detected in the singly infected patients (mean change in IC(50) titer from first to last plasma sample: 183.4) compared to the superinfected study subjects (mean change in IC(50) titer from first to last plasma sample: 66.5). Analysis of the Breadth-Potency Scores confirmed that there was no significant difference in the increase in superinfected and singly infected study subjects (p = 0.234). These studies suggest that while superinfection by discordant subtypes induces antibodies with enhanced neutralizing breadth and potency against heterologous viruses, the potency to neutralize their autologous viruses is not better than those seen in singly infected patients.

Indexed as

Antibodies, NeutralizingCD4 Lymphocyte CountHIV-1HIV InfectionsHumansInhibitory Concentration 50PhylogenyViral LoadAntibodies, Neutralizing

Identifiers

PMID22720009
PMCPMC3375243
OpenAlexW1985475149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.